• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高尔基蛋白 73 在肝细胞癌中的诊断和预后价值。

Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.

机构信息

Department of Gastroenterology, School of Medicine, Ankara University, Ankara, Turkey.

出版信息

Digestion. 2011;83(1-2):83-8. doi: 10.1159/000320379. Epub 2010 Oct 30.

DOI:10.1159/000320379
PMID:21042019
Abstract

BACKGROUND

Golgi protein 73 (GP73) expressions have been detected in hepatocellular carcinoma (HCC) and bile duct carcinoma.

AIM

Our purpose was to determine the serum levels of GP73 in patients with HCC and to compare them with α-fetoprotein (AFP) levels.

MATERIALS AND METHODS

Seventy-five patients with HCC, 55 patients with cirrhosis and 28 healthy controls were included.

RESULTS

The median serum GP73 levels were 0.27 ng/ml (range = 0.078-4.95) in controls, 0.32 ng/ml (range = 0.078-39.63) in cirrhotics and 0.21 ng/ml (range = 0.053-4.98) in those with HCC. The median serum AFP levels were 1.37 ng/ml (range = 0.61-6.89) in controls, 2.32 ng/ml (range = 0.61-85.24) in cirrhotics and 50.65 ng/ml (range = 0.8-37,642) in HCC patients (p < 0.0001 for HCC vs. controls and cirrhotics). The sensitivity, specificity, and positive and negative predictive values of GP73 were 82, 9, 55 and 27%, respectively. Whereas the levels were 68, 94, 94 and 70%, respectively, for AFP(13) and 60, 98, 97 and 64% for AFP(20), respectively. There was no correlation between GP73 levels and other prognostic parameters including tumor size, tumor type, Child-Pugh classification, TNM staging, Cancer of the Liver Italian Program score, portal vein thrombosis and extrahepatic metastasis.

CONCLUSIONS

GP73 has a lower diagnostic and prognostic value for HCC. AFP is superior to GP73 for diagnosis of early HCC.

摘要

背景

高尔基蛋白 73(GP73)的表达已在肝细胞癌(HCC)和胆管癌中被检测到。

目的

本研究旨在测定 HCC 患者血清 GP73 水平,并与甲胎蛋白(AFP)水平进行比较。

材料和方法

纳入 75 例 HCC 患者、55 例肝硬化患者和 28 名健康对照者。

结果

对照组、肝硬化组和 HCC 组患者的中位血清 GP73 水平分别为 0.27ng/ml(范围=0.078-4.95)、0.32ng/ml(范围=0.078-39.63)和 0.21ng/ml(范围=0.053-4.98)。对照组、肝硬化组和 HCC 组患者的中位血清 AFP 水平分别为 1.37ng/ml(范围=0.61-6.89)、2.32ng/ml(范围=0.61-85.24)和 50.65ng/ml(范围=0.8-37,642)(p<0.0001,HCC 组与对照组和肝硬化组比较)。GP73 的敏感性、特异性、阳性预测值和阴性预测值分别为 82%、9%、55%和 27%。而 AFP(13)的水平分别为 68%、94%、94%和 70%,AFP(20)的水平分别为 60%、98%、97%和 64%。GP73 水平与肿瘤大小、肿瘤类型、Child-Pugh 分级、TNM 分期、意大利肝癌计划评分、门静脉血栓形成和肝外转移等其他预后参数之间无相关性。

结论

GP73 对 HCC 的诊断和预后价值较低。AFP 对早期 HCC 的诊断优于 GP73。

相似文献

1
Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.高尔基蛋白 73 在肝细胞癌中的诊断和预后价值。
Digestion. 2011;83(1-2):83-8. doi: 10.1159/000320379. Epub 2010 Oct 30.
2
[Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].[血清高尔基体驻留糖蛋白GP73作为肝细胞癌诊断标志物的检测与评估]
Zhonghua Zhong Liu Za Zhi. 2010 Dec;32(12):943-5.
3
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.高尔基体蛋白73(GP73)是一种驻留高尔基体糖蛋白,是一种新型的肝细胞癌血清标志物。
J Hepatol. 2005 Dec;43(6):1007-12. doi: 10.1016/j.jhep.2005.05.028. Epub 2005 Jun 28.
4
[Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].[新型肿瘤标志物高尔基体糖蛋白73在肝细胞癌诊断中的意义:一项初步研究]
Zhonghua Yi Xue Za Zhi. 2008 Apr 8;88(14):948-51.
5
[Value of combined detection of GP73 and alpha-fetoprotein in diagonosis of hepatocellular carcinoma].[GP73与甲胎蛋白联合检测在肝细胞癌诊断中的价值]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012 Apr;26(2):148-9.
6
[Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].[血清高尔基体蛋白73在肝硬化和原发性肝癌患者中的表达谱及鉴别诊断价值]
Zhonghua Gan Zang Bing Za Zhi. 2012 Dec;20(12):920-4. doi: 10.3760/cma.j.issn.1007-3418.2012.12.010.
7
[Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].血清高尔基体蛋白73在肝细胞癌诊断及病情进展中的临床应用
Zhonghua Yi Xue Za Zhi. 2014 Feb 11;94(5):390-2.
8
Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.高尔基体蛋白73而非磷脂酰肌醇蛋白聚糖-3可能是一种与甲胎蛋白互补用于肝细胞癌诊断的肿瘤标志物。
J Gastroenterol Hepatol. 2014 Mar;29(3):597-602. doi: 10.1111/jgh.12461.
9
[Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma].高尔基体蛋白73在早期原发性肝细胞癌患者中的临床意义及诊断价值
Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):505-8.
10
Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.高尔基体蛋白 73 与甲胎蛋白联合检测在肝细胞癌诊断中的开发及潜在应用。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3302-3310. doi: 10.26355/eurrev_201904_17692.

引用本文的文献

1
Plasma microRNA-15a/16-1-based machine learning for early detection of hepatitis B virus-related hepatocellular carcinoma.基于血浆微小RNA-15a/16-1的机器学习用于早期检测乙型肝炎病毒相关肝细胞癌
Liver Res. 2024 May 24;8(2):105-117. doi: 10.1016/j.livres.2024.05.003. eCollection 2024 Jun.
2
The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.甲胎蛋白(AFP)诊断肝细胞癌的界值:系统评价和荟萃分析。
PLoS One. 2020 Feb 13;15(2):e0228857. doi: 10.1371/journal.pone.0228857. eCollection 2020.
3
Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta-analysis.
中期因子对肝细胞癌的诊断准确性:一项荟萃分析。
Mol Genet Genomic Med. 2020 Feb;8(2):e1071. doi: 10.1002/mgg3.1071. Epub 2019 Nov 27.
4
Golgi protein 73 and its diagnostic value in liver diseases.高尔基体蛋白 73 及其在肝脏疾病中的诊断价值。
Cell Prolif. 2019 Mar;52(2):e12538. doi: 10.1111/cpr.12538. Epub 2018 Oct 19.
5
Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis.高尔基体蛋白73在临床中的异常表达及其在乙型肝炎病毒相关肝细胞癌诊断和预后中的作用
Hepat Mon. 2015 Dec 29;15(12):e32918. doi: 10.5812/hepatmon.32918. eCollection 2015 Dec.
6
Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.血清高尔基体蛋白73对乙型肝炎病毒相关原发性肝癌的诊断价值
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11379-85. eCollection 2015.
7
Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.高尔基体蛋白73与甲胎蛋白联合检测在肝细胞癌中的诊断价值:一项Meta分析
PLoS One. 2015 Oct 6;10(10):e0140067. doi: 10.1371/journal.pone.0140067. eCollection 2015.
8
Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases.用于检测肝病患者血清GP73糖基化改变的多种凝集素检测法
Glycoconj J. 2015 Dec;32(9):657-64. doi: 10.1007/s10719-015-9614-6. Epub 2015 Sep 5.
9
Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?肝细胞癌和胆管癌的筛查:生物标志物能否取代影像学检查?
Curr Hepatol Rep. 2015 Jun;14(2):128-138. doi: 10.1007/s11901-015-0261-y.
10
Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.血清高尔基体蛋白73(GP73)是慢性乙型肝炎肝病的诊断和预后标志物。
Medicine (Baltimore). 2015 Mar;94(12):e659. doi: 10.1097/MD.0000000000000659.